research Systemic Treatment with a KLK5 Inhibitor Shows Efficacy in a Murine Model of Netherton Syndrome
A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.
Search
forLearn
0 / 0 results — no results
Research
5 / 45 resultsresearch Single- And Multiple-Ascending Dose Studies Of DS-2325a, A KLK5 Inhibitor For The Treatment Of Netherton Syndrome
DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.
research New Developments in the Molecular Treatment of Ichthyosis: Review of the Literature
New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.
research LB1256 TRIV-509, A Dual Inhibitor of KLK5 and KLK7, Rapidly Improves Barrier Integrity and Markers of Epidermal Differentiation in Atopic Dermatitis Skin Explants
TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.
research Netherton Syndrome
Netherton syndrome is a genetic skin disorder causing severe skin issues and requires careful treatment to protect the skin barrier.
Community Join
0 / 0 results — no results